| Document Date: 2009-11-26 20:51:00
Open Document File Size: 47,71 KBShare Result on Facebook
Company Adelaide SA / Goldman / / Currency CYP / pence / / Event Product Issues / Product Recall / FDA Phase / / Facility University of South Australia / Sansom Institute / Pharmacy Practice / / IndustryTerm active site / pharmaceutical references / catalytic site / enzyme catalytic site / non-drug chemicals / food interactions / chemicals / food / / MedicalCondition headache / metabolite dissociation / dissociation / / MedicalTreatment complementary medicines / / Organization Sansom Institute / University of South Australia / Adelaide / School of Pharmacy and Medical Sciences / / Person Arch Intern / Ross A McKinnon / Michael B Ward / Michael J Sorich / Allan M Evans / / Position King / Professor / Director / Major / Lecturer / / Product basis of its propensity / clozapine / fluoxetine / phenytoin / metabolic inhibitors / miconazole / itraconazole / drug / theophylline / azithromycin / simvastatin / carbamazepine / ketoconazole / clarithromycin / erythromycin / Kaletra / cimetidine / felodipine / nifedipine / fexofenadine / lovastatin / CYP2C / / ProvinceOrState South Australia / / RadioStation Evans AM / / Region South Australia / / Technology pharmacokinetics / drug metabolism / pharmacogenetics / simulation / DRUG DEVELOPMENT / /
SocialTag |
REVIEW Cytochrome P450 Part 3: Impact of Drug–Drug Interactions Michael B Ward, Michael J Sorich, Allan M Evans, Ross A McKinnon ABSTRACT